Melissa Kujawski
Nurse Practitioner · Grapevine, TXNPI 1376140954
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $39.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$524
- Novo Nordisk$478
- Astellas Pharma US Inc$344
- AstraZeneca$322
- GSK$273
- Amgen$250
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,33898%
- Education$692%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 15 | $524 |
| Novo Nordisk | 10 | $478 |
| Astellas Pharma US Inc | 6 | $344 |
| AstraZeneca | 10 | $322 |
| GSK | 5 | $273 |
| Amgen | 2 | $250 |
| AbbVie | 9 | $237 |
| Pfizer | 2 | $146 |
| Idorsia Pharmaceuticals US Inc | 4 | $142 |
| Axsome Therapeutics, Inc. | 3 | $132 |
| Medtronic | 3 | $127 |
| Otsuka America Pharmaceutical, Inc. | 1 | $116 |
| Corium, LLC | 4 | $104 |
| Phathom Pharmaceuticals, Inc. | 3 | $46 |
| Noven Therapeutics, LLC | 2 | $31 |
| Corcept Therapeutics | 1 | $27 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Bayer | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,407 in reported general payments places this provider in the 90th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 20 | $234 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $172 |
| Omeprazole | 12 | $124 |
| Azithromycin | 11 | $49 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Grapevine
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Onna FeuchterSouthlake$108K
- Stephanie AgrellaRound Rock$102K
- Sue RankinAmarillo$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.